Navigation Links
MitoAction Develops On-Line Resource for Mitochondrial Disease Care Providers
Date:7/23/2008

Online Clinicians Guide to Mitochondrial Disease Now Available, sponsored by Edison Pharma

Boston (PRWEB) July 23, 2008 -- MitoAction.org announces today the completion of the Clinicians Symptom Guide to MITO Management, a comprehensive online resource designed to assist primary care providers in the care and symptom management of patients affected by mitochondrial disease. The Clinicians Symptom Guide to MITO Management fills a gap in healthcare libraries which to date have offered no practical overview for patient management. MitoAction fulfills their mission to support, educate and advocate for the mitochondrial disease patient community through development of the Clinicians Symptom Guide to MITO Management.

Mitochondrial disease is an energy metabolism disorder found in approximately one in 4,000 individuals in the U.S. The disease affects children as well as adults, and commonly manifests with neuromuscular symptoms such as stroke, muscle pain, extreme fatigue, and organ failure. There are no FDA approved drugs for mitochondrial disease. Symptoms vary widely from patient to patient; in many cases, the disease is inherited.

Written in collaboration with Margaret Klehm, CPNP and Mark Korson MD of the Floating Hospital for Children at Tufts Medical Center, the Clinicians Symptom Guide to MITO Management is the only resource of its kind. The Clinicians Symptom Guide to MITO Management is now freely available to the public online at http://www.mitoaction.org/. In light of the recent attention to the autism-mitochondrial disease connection, the need for this practical and comprehensive resource is apparent. This information needs to be accessed by the public and medical providers in order to improve quality of life and care for the person suffering from 'Mito,' says Cristy Balcells, Executive Director of MitoAction.

Dr. Korson is a leading clinician in the field of mitochondrial medicine, and has treated over 1,000 mitochondrial disease patients. This community of patients is terribly under-recognized and underserved. There are simply not enough clinicians aware of Mito, or who will play an active role in the care of these patients. As a result, it is too often the patient or the family member who becomes the de facto primary care provider.

MitoAction anticipates that the Clinicians Symptom Guide to MITO Management will improve baseline care and understanding of the complexities of mitochondrial disease, as well as educate pediatricians, primary care physicians, and home health nurses about managing the disease.

Edison Pharma (http://edisonpharma.com) is the dedicated sponsor for the project. We are honored to support the development of this important resource for clinicians and care-providers, stated Guy Miller, MD, PhD, CEO of Edison. This is a wonderful initiative that will go a long way to standardizing care for patients with mitochondrial disorders. MitoAction is grateful for Edisons support for this project to improve patient care for those affected by mitochondrial disease.

Further questions may be directed to Cristy Balcells, RN MSN Executive Director at 423-914-8322 or director @ mitoaction.org

SOURCE MitoAction

###

Read the full story at http://www.prweb.com/releases/2008/07/prweb1134624.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. HighPoint Solutions Develops Novel Incentive Compensation Plan for New Benign Prostatic Hyperplasia (BPH) Product
2. URAC Develops New Case Management Patient Satisfaction Tool, Invites Public Input On Voluntary Survey Instrument
3. China Sky One Medical, Inc. Successfully Develops Semi-Quantitative Automatic Inspection Device for Diagnostic Kits
4. SellingLTC.com Develops simplifyingLTC
5. Medical Records Institute (MRI) Develops Initiative for EMRs Supporting Medicolegal Requirements
6. Psychologist develops post-operative care for heart patients in Bermuda
7. Omron Healthcare Develops Solar-Powered Digital Blood Pressure Monitors
8. MIT develops thin-film micro pharmacy
9. Capsulated Systems, Inc. Develops Long Term Local Anesthetic
10. OHSU Cancer Institute researcher develops test for targeted therapy in acute myeloid leukemia
11. Silverchair Learning Systems Updates and Develops New Courses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: